WCM
IRWD icon

Weld Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Weld Capital Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-14,993
Closed -$135K – 575
2020
Q3 		$135K Sell
14,993
-105,351
-88% -$1.05M 0.05% 427
2020
Q2 		$1.24M Buy
120,344
+38,394
+47% +$393K 0.49% 47
2020
Q1 		$827K Buy
81,950
+68,789
+523% +$809K 0.42% 60
2019
Q4 		$175K Buy
+13,161
New +$145K 0.03% 545

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Weld Capital Management's IRWD Position: Q4 2020 in Review

Weld Capital Management sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2020, closing a stake of 14,993 shares — an estimated $135K sold.

Weld Capital Management first reported a position in IRWD in Q4 2019 and held it in 4 quarters. The position peaked at $1.24M in Q2 2020. 199 funds tracked by Wall St. Rank hold IRWD as of Q4 2020.

  • Weld Capital Management reported no remaining Ironwood Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Weld Capital Management sold 14,993 Ironwood Pharmaceuticals shares in Q4 2020, an estimated $135K.
  • Weld Capital Management first reported a position in Ironwood Pharmaceuticals in Q4 2019 and held it in 4 quarters.
  • Weld Capital Management's Ironwood Pharmaceuticals position peaked at $1.24M in Q2 2020.
  • 199 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2020.

Based on Weld Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.